Is pathological gambling in Parkinson's disease reduced by amantadine?

Ann Neurol. 2011 Jan;69(1):213-4; author reply 214-5. doi: 10.1002/ana.22289.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Amantadine / therapeutic use*
  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Disruptive, Impulse Control, and Conduct Disorders / drug therapy
  • Disruptive, Impulse Control, and Conduct Disorders / prevention & control
  • Disruptive, Impulse Control, and Conduct Disorders / psychology
  • Female
  • Gambling / chemically induced*
  • Gambling / drug therapy*
  • Gambling / psychology
  • Humans
  • Levodopa / adverse effects
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / psychology
  • Randomized Controlled Trials as Topic / standards
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Levodopa
  • Amantadine